These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 26457542

  • 21. [Vitreous levels of stromal cell-derived factor-1 and vascular endothelial growth factor in diabetic retinopathy].
    Chen L, Lü L, Li Y, Huang X, Zhang J, Li S.
    Yan Ke Xue Bao; 2008 Mar; 24(1):6-8. PubMed ID: 18709948
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Elevated vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy.
    Deng J, Wu DZ, Gao R.
    Yan Ke Xue Bao; 1999 Mar; 15(1):17-21. PubMed ID: 12579655
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Elevated gamma-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy.
    Ambati J, Chalam KV, Chawla DK, D'Angio CT, Guillet EG, Rose SJ, Vanderlinde RE, Ambati BK.
    Arch Ophthalmol; 1997 Sep; 115(9):1161-6. PubMed ID: 9298058
    [Abstract] [Full Text] [Related]

  • 27. Increased prostaglandin E2 (PGE2) levels in proliferative diabetic retinopathy, and correlation with VEGF and inflammatory cytokines.
    Schoenberger SD, Kim SJ, Sheng J, Rezaei KA, Lalezary M, Cherney E.
    Invest Ophthalmol Vis Sci; 2012 Aug 27; 53(9):5906-11. PubMed ID: 22871833
    [Abstract] [Full Text] [Related]

  • 28. Autocrine CCL2, CXCL4, CXCL9 and CXCL10 signal in retinal endothelial cells and are enhanced in diabetic retinopathy.
    Nawaz MI, Van Raemdonck K, Mohammad G, Kangave D, Van Damme J, Abu El-Asrar AM, Struyf S.
    Exp Eye Res; 2013 Apr 27; 109():67-76. PubMed ID: 23352833
    [Abstract] [Full Text] [Related]

  • 29. Identification of VEGF-independent cytokines in proliferative diabetic retinopathy vitreous.
    Bromberg-White JL, Glazer L, Downer R, Furge K, Boguslawski E, Duesbery NS.
    Invest Ophthalmol Vis Sci; 2013 Oct 03; 54(10):6472-80. PubMed ID: 24003089
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Increased vitreous levels of hydroimidazolone in type 2 diabetes patients are associated with retinopathy: a case-control study.
    Fosmark DS, Bragadóttir R, Stene-Johansen I, Berg JP, Berg TJ, Lund T, Sandvik L, Hanssen KF.
    Acta Ophthalmol Scand; 2007 Sep 03; 85(6):618-22. PubMed ID: 17488318
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Role of chemokines in the vitreous of proliferative diabetic retinopathy].
    Kawashima M, Shoji J, Kamura Y, Sato Y.
    Nippon Ganka Gakkai Zasshi; 2005 Sep 03; 109(9):596-602. PubMed ID: 16218438
    [Abstract] [Full Text] [Related]

  • 34. Effects of intravitreal injection of bevacizumab on inflammatory cytokines in the vitreous with proliferative diabetic retinopathy.
    Suzuki Y, Suzuki K, Yokoi Y, Miyagawa Y, Metoki T, Nakazawa M.
    Retina; 2014 Jan 03; 34(1):165-71. PubMed ID: 23851630
    [Abstract] [Full Text] [Related]

  • 35. Association of 150-kDa oxygen-regulated protein with vascular endothelial growth factor in proliferative diabetic retinopathy.
    Abu El-Asrar AM, Ahmad A, Alam K, Bittoun E, Siddiquei MM, Mohammad G, Mousa A, De Hertogh G, Opdenakker G.
    Acta Ophthalmol; 2018 Jun 03; 96(4):e460-e467. PubMed ID: 29098793
    [Abstract] [Full Text] [Related]

  • 36. Risk evaluation of outcome of vitreous surgery based on vitreous levels of cytokines.
    Funatsu H, Yamashita H, Mimura T, Noma H, Nakamura S, Hori S.
    Eye (Lond); 2007 Mar 03; 21(3):377-82. PubMed ID: 16410812
    [Abstract] [Full Text] [Related]

  • 37. Vascular endothelial growth factor in plasma and vitreous fluid of patients with proliferative diabetic retinopathy patients after intravitreal injection of bevacizumab.
    Ma Y, Zhang Y, Zhao T, Jiang YR.
    Am J Ophthalmol; 2012 Feb 03; 153(2):307-313.e2. PubMed ID: 21982107
    [Abstract] [Full Text] [Related]

  • 38. Increased vitreous concentrations of MCP-1 and IL-6 after vitrectomy in patients with proliferative diabetic retinopathy: possible association with postoperative macular oedema.
    Yoshida S, Kubo Y, Kobayashi Y, Zhou Y, Nakama T, Yamaguchi M, Tachibana T, Ishikawa K, Arita R, Nakao S, Sassa Y, Oshima Y, Kono T, Ishibashi T.
    Br J Ophthalmol; 2015 Jul 03; 99(7):960-6. PubMed ID: 25631486
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The impact of ranibizumab on the level of intercellular adhesion molecule type 1 in the vitreous of eyes with proliferative diabetic retinopathy.
    Yan Y, Zhu L, Hong L, Deng J, Song Y, Chen X.
    Acta Ophthalmol; 2016 Jun 03; 94(4):358-64. PubMed ID: 26285163
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.